Marksans Pharma Limited ( MARKSANS.NS) - Stock Earnings
MARKSANS.NS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | 1.5 billion INR | 8.6 billion INR |
| 2026Q2 | 1.6 billion INR | 8.4 billion INR |
| 2026Q3 | 1.4 billion INR | 9.4 billion INR |
MARKSANS.NS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 3.1 billion INR | 21.8 billion INR |
| 2025 | 3.8 billion INR | 26.2 billion INR |
| 2026 | 4.2 billion INR | 29.5 billion INR |
| 2026 Est. | — | — |
MARKSANS.NS
Price: ₹291.15
Forward Dividend Yield: 0.31%
Payout Ratio: 8.16%
Dividend Per Share: 0.90 INR
Earnings Per Share: 12.35 INR
P/E Ratio: 25
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 139.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 13